Official Journal: CADE approves Reckitt Bernckiser,Bristol-Myers Squib's drug-supply deal
MLex Summary: Brazilian competition regulator CADE has approved Reckitt Bernckiser and Bristol - Myers Squib's drug-supply collaboration deal. The three-year agreement covers the sale, distribution and commercialization rights of some of Bristol-Myers' drugs...To view the full article, register now.
Already a subscriber? Click here to view full article